Executive Summit: Emerging Strategic and Financial Issues
in the Pharmaceutical Industry

December 6, 2011
Yale Club, New York City
12:00 PM – 5:00 PM


Luncheon and Summit Co-Sponsored By:

Selected Topics and Speakers

The Impact of the Global Fiscal Crisis on Pharma
William Looney, Editor-In-Chief, Pharmaceutical Executive

The Current and Future State of the Pharmaceutical Industry
Peter Young, President, Young & Partners 

The Pharmaceutical Market: Trends and Forecasts
Doug Long, Vice President, IMS Health Inc.
 
Achieving Success in the China Market
Helen Chen, Partner, Head of China Life Sciences, L.E.K. Consulting Limited (Shanghai)

Pharma M&A: Driving Factors in the Market
Douglas Giordano, SVP Worldwide Business Development, Pfizer, Inc.

Peter Young, President, Young & Partners

European Biotech: The Symphogen Case Study
Kirsten Drejer Ph.D., CEO, Symphogen

Biotech Deal Making – M&A. Licensing and Partnering Trends
Randolph Guggenheimer III, Managing Director, Young & Partners

New Developments in Drug Patent Laws
David Barr, Partner, Kaye Scholer LLP


By invitation only. This event is only for pharma and biotech company senior executives. To apply for an invitation, please email your name, title, company affiliation and contact information to Jason Lacerna or call him at 212-682-5555. If you qualify, you will be invited to attend as guests of the co-sponsors. There will be no charge for the lunch or the summit.

» Apply for an Invitation

Young & Partners is an international investment banking firm focused on providing M&A and financing services to the pharmaceutical, biotech, medical device and diagnostic and chemical industries.

Pharmaceutical Executive is the leading magazine serving the needs of pharmaceutical executives.